Inogen (INGN) Net Cash Flow Growth (1y) (2014 - 2026)
Inogen (INGN) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | 76.43% |
| 10 | Inogen | 174.59 Mn | 64.42 Mn | 37.86 Mn | -310.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -310.48% |
| Dec 31, 2025 | -132.03% |
| Sep 30, 2025 | -67.65% |
| Jun 30, 2025 | -209.49% |
| Mar 31, 2025 | 128.61% |
| Dec 31, 2024 | 755.28% |
| Sep 30, 2024 | 117.93% |
| Jun 30, 2024 | -270.32% |
| Mar 31, 2024 | 21.63% |
| Dec 31, 2023 | 104.29% |
| Sep 30, 2023 | -218.83% |
| Jun 30, 2023 | -66.45% |
| Mar 31, 2023 | -2.67% |
| Dec 31, 2022 | -281.42% |
| Sep 30, 2022 | -574.98% |
| Jun 30, 2022 | -45.12% |
| Mar 31, 2022 | -369.04% |
| Dec 31, 2021 | -163.79% |
| Sep 30, 2021 | 1,125.18% |
| Jun 30, 2021 | 238.70% |